Human Genome Epidemiology Literature Finder
|
Records 1 - 6 (of 6 Records) |
| Query Trace: Neoplasms and PLCG2[original query] |
|---|
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.
Endocrine-related cancer 2013 Dec 20 (6): 875-87. Rudolph Anja, Hein Rebecca, Lindström Sara, Beckmann Lars, Behrens Sabine, Liu Jianjun, Aschard Hugues, Bolla Manjeet K, Wang Jean, Truong Thérèse, Cordina-Duverger Emilie, Menegaux Florence, Brüning Thomas, Harth Volker, , Severi Gianluca, Baglietto Laura, Southey Melissa, Chanock Stephen J, Lissowska Jolanta, Figueroa Jonine D, Eriksson Mikael, Humpreys Keith, Darabi Hatef, Olson Janet E, Stevens Kristen N, Vachon Celine M, Knight Julia A, Glendon Gord, Mulligan Anna Marie, Ashworth Alan, Orr Nicholas, Schoemaker Minouk, Webb Penny M, , , Guénel Pascal, Brauch Hiltrud, Giles Graham, García-Closas Montserrat, Czene Kamila, Chenevix-Trench Georgia, Couch Fergus J, Andrulis Irene L, Swerdlow Anthony, Hunter David J, Flesch-Janys Dieter, Easton Douglas F, Hall Per, Nevanlinna Heli, Kraft Peter, Chang-Claude Jenny, |
| A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density. Breast cancer research : BCR 2015 17 (1): 110. Rudolph Anja, Fasching Peter A, Behrens Sabine, Eilber Ursula, Bolla Manjeet K, Wang Qin, Thompson Deborah, Czene Kamila, Brand Judith S, Li Jingmei, Scott Christopher, Pankratz V Shane, Brandt Kathleen, Hallberg Emily, Olson Janet E, Lee Adam, Beckmann Matthias W, Ekici Arif B, Haeberle Lothar, Maskarinec Gertraud, Le Marchand Loic, Schumacher Fredrick, Milne Roger L, Knight Julia A, Apicella Carmel, Southey Melissa C, Kapuscinski Miroslav K, Hopper John L, Andrulis Irene L, Giles Graham G, Haiman Christopher A, Khaw Kay-Tee, Luben Robert, Hall Per, Pharoah Paul D P, Couch Fergus J, Easton Douglas F, Dos-Santos-Silva Isabel, Vachon Celine, Chang-Claude Jen |
| Novel genetic variants in genes of the Fc gamma receptor-mediated phagocytosis pathway predict non-small cell lung cancer survival. Translational lung cancer research 2020 Jun 9 (3): 575-586. Qian Danwen, Liu Hongliang, Zhao Lingling, Wang Xiaomeng, Luo Sheng, Moorman Patricia G, Patz Edward F, Su Li, Shen Sipeng, Christiani David C, Wei Qing |
| Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab. Blood advances 2021 9 5 (22): 4674-4685. Bruscaggin Alessio, di Bergamo Lodovico Terzi, Spina Valeria, Hodkinson Brendan, Forestieri Gabriela, Bonfiglio Ferdinando, Condoluci Adalgisa, Wu Wei, Pirosa Maria C, Faderl Martin R, Koch Ricardo, Schaffer Michael, Alvarez John D, Fourneau Nele, Gerber Bernhard, Stussi Georg, Zucca Emanuele, Balasubramanian Sriram, Rossi Davi |
| CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 5 OF1-OF10. Anfal Alsadhan, Jonathan Chen, Erika M Gaglione, Chingiz Underbayev, Pamela L Tuma, Xin Tian, Lita A Freeman, Sivasubramanian Baskar, Pia Nierman, Susan Soto, Andy Itsara, Inhye E Ahn, Clare Sun, Elena Bibikova, Tanja Nicole Hartmann, Maissa Mhibik, Adrian Wiestn |
| Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 OF1-OF8. Nitin Jain, Lisa J Croner, John N Allan, Tanya Siddiqi, Alessandra Tedeschi, Xavier C Badoux, Karl Eckert, Leo W K Cheung, Anwesha Mukherjee, James P Dean, Edith Szafer-Glusman, John F Seymo |
- Page last reviewed:Feb 1, 2024
- Content source: